Cocaine opens the blood-brain barrier to HIV-1 invasion

Journal of NeuroVirology

Volumn 4, Issue 6, 1998, Pages 619-626

  Zhang, Ling ^a   Looney, David ^b   Taub, Dennis ^c   Chang, Sulie L ^d   Way, Dennis ^e   Witte, Marlys H ^e   Graves, Michael C ^a   Fiala, Milan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d SETON HALL UNIVERSITY   (United States)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Cocaine; Endothelial cells; HIV 1; Macrophage inflammatory protein 1 ; Monocyte chemoattractant protein 1; Tumor necrosis factor

Indexed keywords

COCAINE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN MICROCIRCULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOCYTE; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032435794     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289809114228     Document Type: Article

References (40)

1. Bacellar H, Munoz A, Miller EN, Cohen BA, Besley D, Seines OA, Becker JT, McArthur JC (1994). Temporal trends in the incidence of HIV-1 related neurologic diseases: Multi-center AIDS Cohort Study 1985-1992. Neurology 44: 1892-1900.
2. Bagasra O, Pomerantz RJ (1993). Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J Infect Dis 168: 1157-1164.
3. Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R, Pomerantz RJ (1996). Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. Aids 10: 573-585.
4. Bell MD, Taub DD, Perry VH (1996). Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience 74: 283-292.
5. Berger EA, Doms RW, Fenyo EM, Korber BTM, Littman DR, Moore JP, Sattentau QJ, Schuitemaker H, Sodroski J, Weiss RA (1998). A new classification for HIV-1. Nature 391: 240.
6. Chao CC, Gekker G, Sheng WS, Hu S, Tsang M, Peterson PK (1994). Priming effect of morphine on the production of tumor necrosis factor-α by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression. J Pharmacol Exp Ther 269: 198-203.
7. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P (1995). Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811-1815.
8. Daras M, Tuchman AJ, Koppel BS, Samkoff LM, Weitzner I, Marc J (1994). Neurovascular complications of cocaine. Acta Neurologica Scandinavian 90: 124-129.
9. Deng HK, Liu R, Ellmeier W, Choe S, Unumatz D, Burkhart M, DiMarzio P et al (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature 381: 661-666.
10. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW (1996). A dual-tropic primary HIV-1 isolate that uses fusin and the beta chemokine receptors CKR5, CKR4 and CKR2b as fusion co-factors. Cell 85: 1149-1158.
11. Edinger AL, Mankowski JL, Doranz BJ, Margulies BJ, Lee B, Rucker J, Sharron M, Hoffman TL, Berson JF, Zink MC, Hirsch VM, Clements JE, Doms RW (1997). CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc Natl Acad Sci USA 94: 14742-14747.
12. Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA, HIV Neurobehavioral Research Center Group (1997). Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 42: 679-688.
13. Elovaara I, Seppala I, Poutianen S, Sun J, Valle S-L (1998). Intrathecal humoral immunologic response in neurologically symptomatic and asymptomatic patients with human immunodeficiency virus infection. Neurology 38: 1451.
14. Feng Y, Broder CC, Kennedy PE, Berger CC (1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G-protein-coupled receptor. Science 272: 872-877.
15. Fiala M, Gan X-H, Newton T, Chiappelli F, Shapshak P, Kermani V, Kung MA, Diagne A, Martinez O, Graves M, Way D, Weinand M, Witte M (1996a). Divergent effects of cocaine on cytokine production by lymphocytes and monocyte/macrophages. Adv Exp Med Biol 402: 145-156.
16. Fiala M, Rhodes RH, Shapshak P, Nagano I, Martinez OM, Diagne A, Baldwin G, Graves M (1996b). Regulation of HIV-1 infection in astrocytes: expression of Nef-α and IL-6 is enhanced in coculture of astrocytes with macrophages. J Neurovirol 2: 158-166.
17. Fiala M, Looney DJ, Stins M, Way D, Zhang L, Gan X, Chiappelli F, Shapshak P, Weinand M, Graves M, Witte M, Kim K-S (1997). TNF-α opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Molecular Medicine 3: 553-564.
18. Gendelman H, Persidsky Y, Ghorpade A, Limoges J, Stins M, Fiala M, Morrisett R (1997). The neuropathogenesis of the AIDS dementia complex. AIDS 11 (suppl A): S35-S45.
19. Gisslén M, Chiodi F, Fuchs D, Norkrans G, Svennerholm B, Wachter H, Hagberg L (1994). Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study. Scand J Infect Dis 26: 523-533.
20. Gray F, Lesces M-C, Keohane C, Paraire F, Marc B, Durignon M, Gherardi R (1992). Early brain changes in HIV infection: Neuropathological study of 11 HIV seropositive, non-AIDS cases. J Neuropathol Exp Neurol 51: 177-185.
21. Handelsman L, Aronson M, Maurer G, Wiener J, Jacobson J, Bernstein D, Ness HS, Lasonczy M, Song IS et al (1992). Neuropsychological and neurological manifestations of HIV-1 dementia in drug users. J Neuropsych Clin Neurosci 4: 21-28.
22. He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W et al (1997). CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385: 645-649.
23. Holman BL, Garada B, Johnson KA, Mendelson J, Hallring E, Teoh SK, Worth J, Navia B (1992). A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. J Nuclear Medicine 33: 1312-1315.
24. Liao F, Alkhatib G, Peden KW, Sharma G, Berger EA, Farber JM (1997). STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med 185: 2015-2023.
25. Kibyashi K, Mastri AR, Hirsch CS (1996). Neuropathology of human immunodeficiency virus infection at different disease stages. Human Pathol 7: 637-642.
26. Koutsilieri E, Gotz ME, Sopper S, Sauer U, Demuth M, ter Meulen V, Riederer P (1997). Regulation of glutathione and cell toxicity following exposure to neurotropic substances and human immunodeficiency virus-1 in vitro. J Neurovirol 3: 342-349.
27. Massari FE, Poli G, Schnittman SM, Psallidopoulos MC, Davey V, Fauci AS (1990). In vivo T lymphocyte origin of macrophage-tropic strains of HIV. Role of monocytes during in vitro isolation and in vivo infection. J Immunol 144: 4628-4632.
28. McArthur JC, Sipos E, Cornblath DR, Welch D, Chupp M, Griffin DE, Johnson RT (1989). Identification of mononuclear cells in CSF of patients with HIV infection. Neurology 39: 66-70.
29. McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER (1997). Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 42: 689-698.
30. Mody CK et al (1988). Neurologic complications of cocaine. Neurology 38: 1181-1183.
31. Moses AV, Bloom FE, Pauza CD, Nelson JA (1993). Human immunodeficiency virus infection of human brain capillary endothelial cells occur via a CD4/ galactosylceramide-independent mechanism. Proc Natl Acad Sci USA 90: 10474-10478.
32. Piatak Jr M, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BC, Shaw GM, Lifson JD (1993). High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259: 1749-1754.
33. Poli G and Fauci AS (1992). The role of monocyte/ macrophages and cytokines in the pathogenesis of HIV infection. Pathobiology 60: 246-251.
34. Robertson K, Fiscus S, Kappor C, Robertson W, Schneider G, Shepard R, Howe L, Silva S, Hall C (1998). CSF, plasma viral load and HIV associated dementia. J Neurovirol 4: 90-94.
35. Schmidtmayerova H, Sherry B, Bukrinsky M (1996). Chemokines and HIV replication. Nature, 382: 676.
36. Spector SA, Hsia K, Pratt D, Lathey J, McCutchan A, Alcara JE, Atkinson JH et al (1993). Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid. J Infect Dis 168: 68-74.
37. Strickland TL et al (1993). Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsych Clin Neurosci 5: 419-427.
38. Wellman MC (1992). Neuropsychological impairment among intravenous drug users in pre-AIDS stages of HIV infection. Int J Neurosci 64: 183-194.
39. Wilt SG, Milward E, Zhou JM, Nagasato K, Patton H, Rusten R, Griffen DE, O'Connor M, Dubois-Dalcq M (1995). In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type 1 (HIV-1) encephalopathy. Ann Neurol 37: 381-394.
40. Wu Y-B, Shen M-L, Gu GG, Anderson KM, Ou DW (1997). The effects of cocaine injections on mouse thymocyte population. Proc Soc Exp Biol Med 214: 173-176.